Anesthesia
Conditions
Interventions
Normal group:none
Sponsors
West China Second University Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. ASA I-II, aged 18-45, 28 weeks of gestation or above;Single live births; 2. Informed consent has been signed; 3. No recent history of cold; 4. Patients without other cardiovascular and cerebrovascular diseases; 5. Patients without any rare diseases; 6. In patients with type 2 diabetes, if the blood glucose level was adjusted by oral administration or injection before surgery, the preoperative blood glucose value fluctuated between 3.61-6.05mmol/L and less than 7.77mmol/L 2 hours after meal.
Exclusion criteria
Exclusion criteria: 1. It cannot cooperate with the research for any reason or the researcher thinks it is not suitable to be included in this trial; 2. Have any of the following medical history and past history: (1) Severe acute or chronic liver disease supported by any of the following indicators: hepatic encephalopathy, varicose veins, hemorrhage, INR> 1.7 without anticoagulation therapy; (2) Patients with malignant tumors of the brain, thyroid, liver and gallbladder; (3) A history of surgery for malignant tumors of the brain, thyroid, liver and gallbladder, as well as a history of radiotherapy and chemotherapy; (4) Recent history of acute infection: history of systemic chronic diseases such as endocrine, metabolism, breathing and circulation; (5) Long-term application history of narcotic analgesics; (6) People with a history of mental illness or neurosis, alcoholism, heavy smoking, and abnormal blood-borne diseases. 3. Have any of the following symptoms or signs (1) Severe COPD or ischemia causes breathing difficulties; (2) Difficulty breathing caused by ischemia; (3) Blood pressure and heart rate meet one of the following: 1) SBP 180 mmHg; 2) DBP 100 mmHg; 3) Resting heart rate> 110 bpm; 4. Laboratory examination: hemoglobin is lower than 8.0 g/dl; 5. The imaging examination confirms that the ejection fraction is less than 45%; 6. Failure to comply with the planned research process.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inhaled drug concentration during anaesthesia recovery; | — |
Countries
China
Contacts
Public ContactLiu Hui
West China Second University Hospital, Sichuan University
Outcome results
None listed